Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MyVaccineLA/MiVacunaLA: A Mobile Phone Delivered Intervention to Improve COVID-19 Vaccination Behaviors Among Vulnerable Latino Families in Los Angeles

NCT05234372 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.

NCT NCT05234372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05234372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MyVaccineLA/MiVacunaLA: A Mobile Phone Delivered Intervention to Improve COVID-19 Vaccination Behaviors Among Vulnerable Latino Families in Los Angeles
Lead sponsor
Cedars-Sinai Medical Center
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2022
Completion date
December 31, 2022
Enrollment
468 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pandemic